Merck Must Pay $8 Million To Fosamax Patient
A jury in New York has ordered Merck & Co. to pay $8 million in damages to a Florida women, after she successfully claimed that Fosamax caused her to develop osteonecrosis of the jaw (ONJ). ONJ is a condition that causes jawbone tissue death. Fosamax. This is the second case involving Fosamax to go to trial this year. In May, a jury ruled in favor of Merck but a third trial is scheduled for November 2010. The outcomes of these trials are expected to provide an indication of what may happen with hundreds of other pending lawsuits that allege that Merck knowingly marketed a potentially dangerous drug, and failed to warn patients of the potential risks involved in taking the medication.
